Discontinuation report CIPROFLOXACIN INJECTION
| Report ID | 120710 |
| Drug Identification Number | 02301296 |
| Brand name | CIPROFLOXACIN INJECTION |
| Common or Proper name | CIPROFLOXACIN INJECTION |
| Company Name | BAXTER CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100mL & 200mL |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2020-07-31 |
| Actual discontinuation date | 2020-07-31 |
| Remaining supply date | 2020-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | This product was never marketed by Baxter Corporation. As such, there is no inventory of this product available. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-08-17 | French | Compare |
| v5 | 2020-08-17 | English | Compare |
| v4 | 2020-07-21 | French | Compare |
| v3 | 2020-07-21 | English | Compare |
| v2 | 2020-07-21 | French | Compare |
| v1 | 2020-07-21 | English | Compare |
Showing 1 to 6 of 6